Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Psilocybin in Chronic Low Back Pain and Depression
Read the official source — NCT06355414Psilocybin and Affective Function in Chronic Lower Back Pain Depression
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Read the official source — NCT07226232A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans
Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression
Read the official source — NCT07183748This study evaluates the safety and effectiveness of psychotherapy for people with depression.
Psilocybin on Brain Mechanisms of Motivation in OUD
Read the official source — NCT06810310Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Read the official source — NCT06405607Psilocybin vs Ketamine for Alcohol Use Disorder
Psilocybin rTMS for Treatment Resistant Depression
Read the official source — NCT06132178This study evaluates the safety and effectiveness of Psilocybin for people with depression.
Psilocybin Therapy for Depression in Parkinson's Disease
Read the official source — NCT06455293This study evaluates the effectiveness of Psilocybin for people with depression.
Psilocybin Therapy for Psychological Distress in Palliative Patients
Read the official source — NCT06782724The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.
Psilocybin to Treat Depression in Spinal Cord Injury
Read the official source — NCT07251491Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.
Read the official source — NCT07347405Researchers are comparing Psilocybin 10 mg, Psilocybin 20 mg and Psilocybin 30 mg to find out how the approaches affect obsessive thoughts and compulsive behaviours in people with OCD.
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Read the official source — NCT06592833Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
Read the official source — NCT05995769Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.